| HTC2 |
|
hypertrichosis 2 (generalized, congenital)
|
|
|
0.392 |
0.808 |
| NEFL |
P07196
|
neurofilament light
|
|
|
0.488 |
0.769 |
| CBLL2 |
Q8N7E2
|
Cbl proto-oncogene like 2
|
Enzyme
|
|
0.476 |
0.808 |
| CYTB |
P00156
|
cytochrome b
|
|
|
0.529 |
0.808 |
| XIST |
|
X inactive specific transcript
|
|
|
0.522 |
0.808 |
| CBSL |
P0DN79 P35520
|
cystathionine beta-synthase like
|
|
|
0.540 |
0.808 |
| H3P8 |
|
H3 histone pseudogene 8
|
|
|
0.544 |
0.808 |
| WT1-AS |
Q06250
|
WT1 antisense RNA
|
|
|
0.597 |
0.615 |
| FRAXA |
|
fragile site, folic acid type, rare, fra(X)(q27.3) A (macroorchidism, mental retardation)
|
|
|
0.641 |
0.462 |
| FRAXE |
|
fragile site, folic acid type, rare, fra(X)(q28) E
|
|
|
0.636 |
0.462 |
| PRS |
|
Prieto X-linked mental retardation syndrome
|
|
|
0.663 |
0.615 |
| DCR |
|
Down syndrome chromosome region
|
|
|
0.674 |
0.538 |
| FMR1-IT1 |
|
FMR1 intronic transcript 1
|
|
|
0.716 |
0.385 |
| DEL11P13 |
|
Wilms tumor, aniridia, genitourinary anomalies and mental retardation syndrome
|
|
|
0.716 |
0.538 |
| AQP4-AS1 |
|
AQP4 antisense RNA 1
|
|
|
0.751 |
0.577 |
| MBS1 |
|
Moebius syndrome 1
|
|
|
0.805 |
0.308 |
| XIC |
|
X chromosome inactivation center
|
|
|
0.821 |
0.462 |
| MRX49 |
|
mental retardation, X-linked 49
|
|
|
0.821 |
0.385 |
| MEHMO |
|
mental retardation, epileptic seizures, hypogonadism and -genitalism, microcephaly and obesity syndrome
|
|
|
0.890 |
0.269 |
| ENFL2 |
|
Epilepsy, nocturnal frontal lobe, type 2
|
|
|
0.839 |
0.346 |
| VCY |
O14598
|
variable charge Y-linked
|
|
|
0.890 |
0.231 |
| GDI2P1 |
|
GDP dissociation inhibitor 2 pseudogene 1
|
|
|
0.931 |
0.192 |
| FRA12A |
|
fragile site, folic acid type, rare, fra(12)(q13.1)
|
|
|
1.000 |
0.192 |
| ASPM |
Q8IZT6
|
abnormal spindle microtubule assembly
|
|
3.4E-49 |
0.526 |
0.769 |
| LAMA2 |
P24043
|
laminin subunit alpha 2
|
Enzyme modulator
|
2.4E-47 |
0.553 |
0.692 |